The present invention relates to pharmaceutical compositions for the prevention and/or treatment of pathological processes involving the induction of TNF-.alpha. secretion comprising a pharmaceutically acceptable carrier and a low molecular weight heparin (LMWH). In the pharmaceutical compositions of...http://www.google.es/patents/US5908837?utm_source=gb-gplus-sharePatente US5908837 - Methods of using low molecular weight heparins for prevention or treatment of pathological processes
Methods of using low molecular weight heparins for prevention or treatment ...
